Recent psychostimulant use in hospitalized schizophrenics.
The incidence of CNS stimulant use among 300 patients admitted to an acute care psychiatric facility was estimated to be 31% overall; 11% of patients admitted to use within 6 months of the index hospitalization. A number of previously described relationships between stimulant use and schizophrenia were confirmed. Relapsing schizophrenics utilized stimulants prior to hospitalization more often than nonschizophrenic patients; outpatient antipsychotic prophylaxis did not prevent these relapses. It is concluded that stimulants partially contribute to relapse in schizophrenics.
Richard
M L
ML
Liskow
B I
BI
Perry
P J
PJ
D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D006760:Hospitalization; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D007484:Iowa; D008297:Male; D008875:Middle Aged; D011567:Psychiatric Department, Hospital; D012008:Recurrence; D012559:Schizophrenia / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D012565:Schizophrenic Psychology; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D013287:Illicit Drugs